The National Times - Springsteen releases fiery ode to Minneapolis shooting victims

Springsteen releases fiery ode to Minneapolis shooting victims


Springsteen releases fiery ode to Minneapolis shooting victims
Springsteen releases fiery ode to Minneapolis shooting victims / Photo: © AFP/File

American rock hero Bruce Springsteen dived into the outrage over the Trump administration's immigration crackdown with a fiery song released Wednesday that pays tribute to two protesters fatally shot by federal agents in Minneapolis.

Change text size:

Springsteen said the song "Streets of Minneapolis" was a response to "state terror" in the northern US city, rocked by the actions of armed federal officers that have stoked vociferous local protests.

"I wrote this song on Saturday, recorded it yesterday and released it to you today in response to the state terror being visited on the city" in the state of Minnesota, The Boss wrote on his Instagram page.

"It's dedicated to the people of Minneapolis, our innocent immigrant neighbors and in memory of Alex Pretti and Renee Good," the 76-year-old wrote, referring to the two US nationals killed this month. Pretti died after a scuffle with agents on a snowy Minneapolis street on Saturday.

"Stay free," Springsteen added.

The "Born to Run" and "Badlands" singer has often been willing to criticize President Donald Trump with very blunt language in interviews and at performances, and the anthemic song he released online Wednesday pulls no punches.

It refers to the several thousand immigration agents who descended on Minneapolis as "King Trump's private army" wearing "occupiers' boots" and with "guns belted to their coats" as they undertake Trump's push to deport undocumented immigrants.

"There were bloody footprints where mercy should have stood, and two dead left to die on snow-filled streets: Alex Pretti and Renee Good," he sings in the opening verse.

The chorus: "Oh Minneapolis I hear your voice, crying through the bloody mist. We'll remember the names of those who died on the streets of Minneapolis."

The song's title echoes the 1994 classic "Streets of Philadelphia," Springsteen's haunting ballad about people living with AIDS.

For decades, Springsteen has been revered by rock fans in the United States and beyond for his man-of-the-people guitar music and socially conscious, working-class anthems like "Born in the USA," "The River," and "Rosalita."

During the 2024 election campaign that led to Trump's second presidency, Springsteen threw his support behind Democratic candidate Kamala Harris, and said Trump was running to be an "American tyrant."

At that time he said of Trump, "He does not understand this country, its history or what it means to be deeply American."

Trump has in recent days sought to tamp down the furor over the violence in Minneapolis and has shuffled the leadership of immigration agents deployed there, putting a less confrontational figure in charge.

But on Wednesday he warned the mayor of Minneapolis that he is "playing with fire" with his refusal to cooperate with federal authorities.

M.Davis--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size: